Analisi di impatto sul budget di differenti analoghi ad azione rapida dell’insulina in Italia

Introduction:Rapid-acting insulins are the current standard of care in diabetes management. Insulin aspart (IA), lispro (IL) and glulisine (IG) demonstrated similar efficacy and safety. However, th...